CN1121390C - 用于良性前列腺增生治疗的新的取代吡啶基芳基哌嗪化合物 - Google Patents

用于良性前列腺增生治疗的新的取代吡啶基芳基哌嗪化合物 Download PDF

Info

Publication number
CN1121390C
CN1121390C CN99803027A CN99803027A CN1121390C CN 1121390 C CN1121390 C CN 1121390C CN 99803027 A CN99803027 A CN 99803027A CN 99803027 A CN99803027 A CN 99803027A CN 1121390 C CN1121390 C CN 1121390C
Authority
CN
China
Prior art keywords
compound
alkyl
hydrogen atom
phenyl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99803027A
Other languages
English (en)
Chinese (zh)
Other versions
CN1291188A (zh
Inventor
G·-H·郭
W·V·默累
C·P·普罗蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3 Dimensional Pharmaceuticals Inc
Original Assignee
3 Dimensional Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 Dimensional Pharmaceuticals Inc filed Critical 3 Dimensional Pharmaceuticals Inc
Publication of CN1291188A publication Critical patent/CN1291188A/zh
Application granted granted Critical
Publication of CN1121390C publication Critical patent/CN1121390C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN99803027A 1998-02-20 1999-02-19 用于良性前列腺增生治疗的新的取代吡啶基芳基哌嗪化合物 Expired - Fee Related CN1121390C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
US60/075321 1998-02-20
US60/075,321 1998-02-20

Publications (2)

Publication Number Publication Date
CN1291188A CN1291188A (zh) 2001-04-11
CN1121390C true CN1121390C (zh) 2003-09-17

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99803027A Expired - Fee Related CN1121390C (zh) 1998-02-20 1999-02-19 用于良性前列腺增生治疗的新的取代吡啶基芳基哌嗪化合物

Country Status (23)

Country Link
US (1) US6218396B1 (enExample)
EP (1) EP1054868B1 (enExample)
JP (1) JP2002503724A (enExample)
KR (1) KR100591028B1 (enExample)
CN (1) CN1121390C (enExample)
AR (1) AR014626A1 (enExample)
AT (1) ATE250580T1 (enExample)
AU (1) AU766398B2 (enExample)
BR (1) BR9909647A (enExample)
CZ (1) CZ294136B6 (enExample)
DE (1) DE69911582T2 (enExample)
DK (1) DK1054868T3 (enExample)
ES (1) ES2209468T3 (enExample)
HU (1) HUP0100781A3 (enExample)
IL (2) IL137954A0 (enExample)
NO (1) NO317103B1 (enExample)
NZ (1) NZ506462A (enExample)
PL (1) PL342339A1 (enExample)
PT (1) PT1054868E (enExample)
TR (1) TR200003220T2 (enExample)
TW (1) TW565555B (enExample)
WO (1) WO1999042448A1 (enExample)
ZA (1) ZA991315B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984777B1 (en) * 1997-05-12 2003-09-17 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
HUP0302893A3 (en) 2000-08-08 2006-04-28 Ortho Mcneil Pharm Inc Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
CN1589153A (zh) * 2001-12-28 2005-03-02 武田药品工业株式会社 排尿紊乱的预防或治疗
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
EP2535330A3 (en) * 2006-10-23 2012-12-26 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN102066327B (zh) * 2008-04-23 2013-05-29 武田药品工业株式会社 亚氨基吡啶衍生物及其用途
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1132508A (zh) * 1993-07-30 1996-10-02 里苛达梯化学与药物股份有限公司 哌嗪衍生物
CN1136039A (zh) * 1994-11-08 1996-11-20 弗·哈夫曼-拉罗切有限公司 [3-(4-苯基哌嗪-1-基)丙氨基、硫基和氧基]-吡啶、嘧啶和苯衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
WO1999003833A1 (fr) * 1997-07-15 1999-01-28 Sankyo Company, Limited Derives de piperazine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1132508A (zh) * 1993-07-30 1996-10-02 里苛达梯化学与药物股份有限公司 哌嗪衍生物
CN1136039A (zh) * 1994-11-08 1996-11-20 弗·哈夫曼-拉罗切有限公司 [3-(4-苯基哌嗪-1-基)丙氨基、硫基和氧基]-吡啶、嘧啶和苯衍生物

Also Published As

Publication number Publication date
DK1054868T3 (da) 2003-12-22
AR014626A1 (es) 2001-03-28
TR200003220T2 (tr) 2001-04-20
PL342339A1 (en) 2001-06-04
ES2209468T3 (es) 2004-06-16
HK1030776A1 (en) 2001-05-18
KR100591028B1 (ko) 2006-06-22
NO20004141D0 (no) 2000-08-18
KR20010041115A (ko) 2001-05-15
CN1291188A (zh) 2001-04-11
JP2002503724A (ja) 2002-02-05
EP1054868B1 (en) 2003-09-24
WO1999042448A1 (en) 1999-08-26
TW565555B (en) 2003-12-11
CZ294136B6 (cs) 2004-10-13
IL137954A (en) 2007-06-03
BR9909647A (pt) 2000-11-21
PT1054868E (pt) 2004-01-30
NO317103B1 (no) 2004-08-09
NO20004141L (no) 2000-10-19
ZA991315B (en) 2000-11-20
ATE250580T1 (de) 2003-10-15
IL137954A0 (en) 2001-10-31
US6218396B1 (en) 2001-04-17
AU766398B2 (en) 2003-10-16
DE69911582T2 (de) 2005-09-15
DE69911582D1 (de) 2003-10-30
AU3302599A (en) 1999-09-06
CZ20003044A3 (cs) 2001-04-11
EP1054868A1 (en) 2000-11-29
HUP0100781A2 (hu) 2001-08-28
NZ506462A (en) 2003-07-25
HUP0100781A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
CN1216864C (zh) 烟碱性受体激动剂的正调节剂
CN1273451C (zh) 哌啶mch拮抗剂及其治疗肥胖症的用途
CN1520293A (zh) 作为抗糖尿病药物的3-氟-吡咯烷类
CN1649845A (zh) 蝇蕈碱拮抗剂
CN1816332A (zh) 3－氨基甲基－吡咯烷作为n－型钙通道阻断剂
CN1910150A (zh) 作为gcs抑制剂的哌啶衍生物
CN1867338A (zh) 作为甘氨酸转运蛋白抑制剂的二环[3.1.0]衍生物
CN1146559C (zh) 毒蕈碱性拮抗剂
CN1455769A (zh) 用作β－3肾上腺素能受体激动剂的环胺磺酰胺
CN1121390C (zh) 用于良性前列腺增生治疗的新的取代吡啶基芳基哌嗪化合物
CN101035783A (zh) 作为钙通道阻断剂的脲衍生物
CN1492863A (zh) 作为5-羟色胺-6配基的杂环基烷基-吲哚或氮杂吲哚化合物
CN1642913A (zh) 用作趋化因子受体活性(尤其是ccr5)调节剂的哌啶或8－氮杂－二环[3.2.1]辛－3－基衍生物
CN1729173A (zh) N－(吲哚乙基)环胺化合物
CN1149081C (zh) 可用于治疗良性前列腺肥大的芳基取代哌嗪
CN1095836C (zh) 苯并咪唑衍生物
HK1045517B (zh) 环丁烯二酮化合物及其制备方法和含这些化合物的药物组合物
CN1688307A (zh) 4－氨基哌啶衍生物,它们的制备方法和它们作为药物的用途
CN1291185A (zh) 作为α－1A受体拮抗剂的用于治疗良性前列腺增生phtalmido芳基哌嗪
CN1133622C (zh) 脲基哌啶衍生物作为人类nk3受体的选择性拮抗剂
CN1859907A (zh) 作为黑素浓集激素受体的选择性拮抗剂用于治疗肥胖症和相关病症的氨基苯并咪唑类
CN1466573A (zh) 5-苯基苄胺化合物、其制备方法以及其合成中间体
CN1142913C (zh) 四氢异喹啉烷醇衍生物及其药物组合物
US6063785A (en) Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
CN1886370A (zh) N－酰基－n′－苄基－亚烷基二氨基衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030917

Termination date: 20100219